Scientific deep-dive
Where to Get Orforglipron (Foundayo): How to Get the GLP-1 Pill (2026)
How to get Foundayo (orforglipron), the first FDA-approved oral GLP-1 pill: the LillyDirect route, your own doctor plus a pharmacy, insurance vs self-pay pricing, the savings card rules, and cheaper alternatives.
Foundayo (orforglipron) is the first oral non-peptide GLP-1 receptor agonist, FDA-approved on April 1, 2026, and made by Eli Lilly.[1] To get it, you need a prescription from a licensed provider — there is no over-the-counter version and no legal compounded or generic orforglipron, because the drug is brand-only and on-patent. The most direct route is LillyDirect, Lilly's own telehealth-and-pharmacy platform, which can connect you with a clinician and ship the medication; the standard alternative is a prescription from your own doctor filled at a retail pharmacy.[2] With commercial insurance plus the manufacturer savings card, eligible patients pay as little as about $25 per month; self-pay runs roughly $149–$349 per month by dose tier through LillyDirect.[2][3] This guide walks through every legitimate way to get Foundayo, who can prescribe it, what it costs with and without insurance, why "compounded orforglipron" is a red flag, and the cheaper alternative GLP-1 paths if brand orforglipron is out of reach. See our Foundayo drug page for the full clinical profile. This is general information, not medical advice — your prescriber individualizes your care.
About this article
Every factual claim below — the FDA approval date and the brand-only, non-peptide status of orforglipron; the LillyDirect direct-to-consumer route; and the savings-card eligibility rules including the Medicare and Medicaid exclusion — is anchored to a primary source: the Eli Lilly FDA-approval press release, the LillyDirect platform, and the FDA-approved FOUNDAYO Prescribing Information.[1][2][3] Pricing is stated as the manufacturer's launch-period figures and changes over time, so treat any dollar amounts as approximate and confirm the current price with LillyDirect or your pharmacy. Because orforglipron is on-patent, there is no FDA-approved compounded or generic version; any seller offering "compounded orforglipron" is a red flag. This is general educational information, not medical advice — your prescriber decides whether Foundayo is appropriate for you.
Do you need a prescription for Foundayo?
Yes. Foundayo (orforglipron) is a prescription-only medication — you cannot buy it over the counter, and there is no legitimate way to obtain it without a prescription from a licensed provider.[3] A clinician confirms that you meet the eligibility criteria for chronic weight management before writing the prescription. The prescription requirement is the same whether you go through LillyDirect's telehealth clinicians or through your own doctor; the only thing that changes is who writes it and where it is filled.
Because orforglipron is the active ingredient in a brand-only, on-patent product, there is exactly one legitimate form: brand-name Foundayo from Eli Lilly. There is no FDA-approved generic orforglipron and no compounded orforglipron — a point we return to below, because "compounded orforglipron" offers are a reliable sign of a scam or an unregulated grey-market product.
Who can prescribe orforglipron?
Any licensed provider with prescribing authority can prescribe Foundayo if they determine it is clinically appropriate — that includes your primary-care physician, an endocrinologist, an obesity-medicine specialist, a nurse practitioner, or a physician assistant. You do not need a specialist; many people get orforglipron from the same primary-care doctor who manages the rest of their care.
If you do not have a treating prescriber, or you would rather handle the whole process online, a telehealth clinician can evaluate you and write the prescription. LillyDirect partners with independent telehealth providers for exactly this reason, and a number of third-party telehealth platforms can also prescribe brand Foundayo and route it to a pharmacy. The clinician's job in every case is the same: confirm your eligibility for chronic weight management, review your medical history and current medications, and decide whether orforglipron is a safe and appropriate choice for you.
Route 1 — LillyDirect (the direct-to-consumer path)
LillyDirect (lillydirect.lilly.com) is Eli Lilly's own direct-to-patient platform — it combines a telehealth referral service with a pharmacy that dispenses and ships the medication.[2] It is the most direct way to get Foundayo because it bundles the prescription and the fill into one workflow, and because the product comes straight through Lilly's own channel there is no question about authenticity. Here is how the route works step by step:
- Step 1 — Create an account and complete the intake. Go to lillydirect.lilly.com and start the weight-management flow. You answer a medical-history questionnaire covering your weight, BMI, any weight-related conditions, current medications, and contraindications.
- Step 2 — Connect with a provider (or use your own). If you do not already have a prescription, LillyDirect connects you with an independent telehealth clinician who reviews your intake and decides whether Foundayo is appropriate. If you already have a Foundayo prescription from your own doctor, you can have it sent to the LillyDirect pharmacy instead.
- Step 3 — Confirm eligibility and the prescription is issued. The clinician confirms you meet the chronic-weight-management criteria. There is no guarantee of a prescription — if Foundayo is not appropriate for you, the clinician will not write it.
- Step 4 — Choose insurance or self-pay and pay. You can run the prescription through your commercial insurance (with the savings card applied where eligible) or pay the self-pay price directly. LillyDirect shows your price before you check out.
- Step 5 — The pharmacy ships your medication. Foundayo is a once-daily tablet that does not require refrigeration, so it ships by standard mail with no cold-chain handling. Refills are managed through your account.
Why the oral-tablet format makes the direct route easy
Foundayo is a once-daily tablet you can take at any time of day, with or without food, and it needs no refrigeration.[3] That is a meaningful practical advantage over injectable GLP-1s: there is no cold-chain shipping to coordinate, no autoinjector to learn, and no special storage at home — which is part of why a mail-order, direct-to-patient channel like LillyDirect works so smoothly for orforglipron.
Route 2 — Your own doctor plus a retail pharmacy
The traditional route works just as well. Book an appointment with your primary-care provider or a weight-management specialist, discuss whether orforglipron is right for you, and — if they agree — have them send a prescription to your pharmacy of choice (CVS, Walgreens, Walmart, a local independent, or a mail-order pharmacy). You then pick it up or have it delivered like any other prescription.
This route is the natural choice if you already have a doctor who manages your weight or related conditions, if you want your full care coordinated in one place, or if you would rather use your existing pharmacy and insurance setup. You can still apply the manufacturer savings card at a retail pharmacy if you have eligible commercial insurance — the card is not exclusive to LillyDirect. The trade-off versus LillyDirect is simply that you coordinate the appointment and the fill yourself rather than having them bundled.
What Foundayo costs: insurance vs self-pay
Your out-of-pocket cost for Foundayo depends almost entirely on whether you have eligible commercial insurance and the manufacturer savings card, versus paying cash:
| Path | Who it is for | Approximate monthly cost |
|---|---|---|
| Commercial insurance + savings card | Patients with eligible commercial (non-government) insurance | Starting at about $25/month |
| Self-pay via LillyDirect | Uninsured patients, or those whose plan does not cover Foundayo | About $149–$349/month by dose tier |
| Retail pharmacy, no insurance, no card | Cash at the counter without any program | Higher — confirm at your pharmacy |
| Medicare / Medicaid | Government-program beneficiaries | Plan-dependent; savings card NOT eligible |
The self-pay price through LillyDirect is dose-tiered — roughly $149 to $349 per month depending on the strength you are prescribed — so your exact cash price depends on where you are in the titration schedule.[2] For a deeper cost breakdown and how Foundayo compares with the cash-pay price of every other GLP-1, see our cheapest GLP-1 without insurance buyer's guide.
The savings card — and the Medicare/Medicaid exclusion
Eli Lilly offers a manufacturer savings card that can bring eligible commercial-insurance patients down to about $25 per month for Foundayo.[2] As with every manufacturer copay card in this class, eligibility is limited to patients with commercial (private) insurance. If you are enrolled in Medicare, Medicaid, or any other federal or state government healthcare program, you are not eligible for the savings card — this is a hard exclusion required by federal anti-kickback rules, not a Lilly policy choice. Government-program beneficiaries pay whatever their plan's coverage and formulary allow, which varies widely. If you have Medicare or Medicaid, ask your plan whether Foundayo is on the formulary and what your copay would be, rather than counting on the card.
Why there is no compounded orforglipron (and the scam warning)
Orforglipron is a new, on-patent, brand-only medication. That means there is no FDA-approved generic orforglipron and — critically — no legal compounded orforglipron. Compounding pharmacies are generally only permitted to compound a copy of a commercially available drug under narrow circumstances, such as a documented drug shortage; orforglipron is a freshly launched patented product that is not in shortage, so broad commercial compounding of it is not permitted.
The practical takeaway is simple: if a website, clinic, or telehealth seller offers you "compounded orforglipron," treat it as a red flag. What you would actually be buying is an unregulated grey-market or research-chemical product with no FDA quality testing — no verified identity, purity, sterility, or dose accuracy — and likely a legal-liability shield ("for research use only") that does nothing to protect you. The only legitimate orforglipron is brand-name Foundayo from Eli Lilly, obtained with a prescription through LillyDirect, your doctor plus a pharmacy, or another licensed channel.
Eligibility: who can get Foundayo
Foundayo is approved for chronic weight management — that generally means adults with obesity, or adults who are overweight and also have a weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol). A clinician confirms your eligibility based on your BMI, your weight-related conditions, your medical history, and a review of your current medications and any contraindications. There is no self-qualification: the prescriber makes the call, and if orforglipron is not appropriate for you, they will not prescribe it. To understand what to expect once you start, see our week-by-week Foundayo titration guide.
Cheaper alternative paths if brand Foundayo is out of reach
If you cannot get or afford brand Foundayo — for example you are uninsured, on Medicare or Medicaid without coverage, or simply want the lowest-cost GLP-1 option — there are legitimate alternatives. They are different molecules and (in two of the three cases) injectables, but they are the most affordable real GLP-1 routes:
- Compounded semaglutide or tirzepatide (injectable). Vetted telehealth providers offer compounded semaglutide or tirzepatide injections at roughly $99–$199/month — far below brand orforglipron. These are a different molecule and an injectable rather than a pill, and the regulatory status of broad commercial compounding is unsettled, so use a LegitScript-certified provider with a licensed dispensing pharmacy. This is the most affordable GLP-1 route for many people.
- Oral semaglutide (Rybelsus) by prescription. If you specifically want a pill, Rybelsus (oral semaglutide) is an FDA-approved oral GLP-1 you can get by prescription. It uses a different absorption mechanism than orforglipron and requires a fasting-window dosing protocol, but it is a legitimate brand alternative in tablet form.
- Brand injectable GLP-1s with their own savings programs. Wegovy and Zepbound have manufacturer cash-pay channels and savings cards of their own that may land cheaper than Foundayo for some patients, depending on dose and coverage.
To weigh a pill against an injection, see our comparison of oral GLP-1 pills vs the injectables, which covers how Foundayo, Rybelsus, and oral Wegovy stack up against the subcutaneous options on convenience, magnitude, and cost.
Cheaper alternative — top vetted compounded GLP-1 providers (injectable)
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
No insurance needed · HSA/FSA eligible · vetted by our editors
Breeze Meds
Compounded GLP-1 access with named prescribers and 4-pharmacy network
Starting price: $199/mo
Get started →Read review Breeze Meds →RNK Health
Compounded GLP-1 alongside NAD+, peptide and longevity add-ons
Starting price: $197/mo
Get started →Read review RNK Health →Wellorithm
Compounded GLP-1 access with oral tablet options across 49 states
Starting price: $247/mo
Get started →Read review Wellorithm →SkinnyRx
Mainstream telehealth GLP-1 access
Starting price: $149.25/mo
Get started →Read review SkinnyRx →| Provider | Starting price | |
|---|---|---|
7.4Breeze Meds | $199/mo | Get started → |
8.1GobyMeds | $169/mo | Get started → |
7.6RNK Health | $197/mo | Get started → |
6.2Wellorithm | $247/mo | Get started → |
7.6SkinnyRx | $149.25/mo | Get started → |
Want a clinician-led shortlist instead of the full table? Our editors' picks live on the best semaglutide providers page, with the scoring and verification behind each ranking.
Bottom line
- Foundayo (orforglipron) is the first oral non-peptide GLP-1 pill, FDA-approved April 1, 2026, from Eli Lilly — and it requires a prescription from a licensed provider.[1][3]
- The most direct way to get it is LillyDirect (lillydirect.lilly.com), Lilly's own telehealth-plus-pharmacy platform; the standard alternative is your own doctor's prescription filled at a retail pharmacy.[2]
- With eligible commercial insurance plus the savings card, Foundayo starts at about $25/month; self-pay via LillyDirect runs roughly $149–$349/month by dose tier.[2]
- Medicare and Medicaid beneficiaries are not eligible for the savings card — they pay whatever their plan's formulary allows.
- There is no legal compounded or generic orforglipron — it is brand-only and on-patent. Any "compounded orforglipron" offer is a red flag.
- If brand Foundayo is out of reach, the cheapest legitimate GLP-1 routes are compounded semaglutide or tirzepatide injectables (~$99–$199/month from vetted telehealth) or oral semaglutide (Rybelsus) by prescription.
Frequently asked questions
Frequently Asked Questions
References
- 1.Eli Lilly and Company. FDA Approves Lilly's Foundayo (orforglipron), the Only GLP-1 Pill. Press release announcing FDA approval of Foundayo (orforglipron), the first oral non-peptide GLP-1 receptor agonist, on April 1, 2026, for chronic weight management. Establishes the brand-only, on-patent status of the product and Eli Lilly as the manufacturer. Eli Lilly and Company. 2026. https://investor.lilly.com/news-releases/news-release-details/fda-approves-lillys-foundayotm-orforglipron-only-glp-1-pill
- 2.LillyDirect. LillyDirect — Eli Lilly's direct-to-patient telehealth and pharmacy platform. Connects patients with independent telehealth clinicians and dispenses and ships Lilly medications including Foundayo. Source for the direct-to-consumer route, the savings-card eligibility (commercial insurance, starting at about $25/month), and the dose-tiered self-pay pricing (about $149–$349/month). LillyDirect. 2026. https://lillydirect.lilly.com
- 3.U.S. Food and Drug Administration. FOUNDAYO (orforglipron) tablets, for oral use — FDA-approved Prescribing Information. Source for the prescription-only status, the chronic-weight-management indication and eligibility, and the once-daily oral administration (any time of day, with or without food, no refrigeration required). FDA Approved Labeling. 2026.
- 4.Ma X, Liu R, Pratt EJ, Benson CT, Bhattachar SN, Sloop KW. Effect of Food Consumption on the Pharmacokinetics, Safety, and Tolerability of Once-Daily Orally Administered Orforglipron (LY3502970), a Non-peptide GLP-1 Receptor Agonist. Clinical pharmacokinetics study confirming orforglipron is a non-peptide GLP-1 receptor agonist dosed once daily by the oral route. Diabetes Ther. 2024. PMID: 38402332.
Related research
Best ED Telehealth Providers 2026: Ranked Honest Review
Weight Loss Rankings' 2026 ranking of erectile dysfunction telehealth providers — BraveRx, Hims, Ro, Rugiet Health, and BlueChew — by price, drug formulary, state availability, pharmacy partner, and FDA status. Honest on compounded vs branded.
12 min read
Orforglipron vs Rybelsus: How the Two Oral GLP-1 Pills Compare (2026)
Orforglipron (Foundayo) vs Rybelsus (oral semaglutide): a 2026 head-to-head on molecule type, indication, how you take each, effectiveness, cost, and side effects — and who should pick which.
9 min read
Orforglipron (Foundayo) Cost: Price With & Without Insurance, and Cheaper GLP-1 Options (2026)
Foundayo (orforglipron) runs about $25/month with commercial insurance or $149–$349/month self-pay via LillyDirect. What it costs, why there's no compounded version, and cheaper GLP-1 options.
8 min read
Naltrexone for Weight Loss + How Contrave Actually Works: Evidence Review
Naltrexone alone is not FDA-approved for weight loss. Contrave (naltrexone HCl 32 mg + bupropion HCl 360 mg/day ER) is FDA-approved since September 2014 and produced -6.1% mean weight loss at 56 weeks in the COR-I phase 3 trial (Greenway et al., Lancet 2010, PMID 20673995). Mechanism: bupropion stimulates hypothalamic POMC neurons; naltrexone removes the beta-endorphin autoreceptor brake. Verbatim FDA label (DailyMed SetID 485ff360-32c8-11df-928b-0002a5d5c51b): dosing ladder, boxed warning, adverse reactions table, and contraindications. Cross-trial comparison vs. Wegovy (-14.9%, STEP-1) and Zepbound (-20.9%, SURMOUNT-1) with mandatory cross-trial caveat. Who Contrave is and is not right for. Verified 2026-05-10.
14 min read
Foundayo vs Wegovy: Head-to-Head Evidence Comparison
Foundayo (orforglipron) is an oral small-molecule GLP-1 tablet; Wegovy (semaglutide) is a once-weekly injection. ATTAIN-1 labeled-dose ~11.1% TBWL vs STEP-1 Wegovy ~14.9%. Trial data, side effects, CV evidence, form factor, and a decision framework.
14 min read
Foundayo (Orforglipron) Side Effects: Comprehensive Evidence Review
Comprehensive Foundayo (orforglipron) adverse-event review across the three pivotal trials: ATTAIN-1 in obesity, ATTAIN-2 in T2D, and ATTAIN-MAINTAIN switch-and-maintain. GI dominance, dose discontinuations, class warnings, and head-to-head AE comparison with Wegovy and Zepbound.
14 min read
Where to get GLP-1 safely: vetted online providers
Vetted telehealth providers that prescribe online. We compare pricing, form, and states served.
No insurance needed · vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Found
Mainstream telehealth GLP-1 access
Pricing Compare
Get started →Breeze Meds
Compounded GLP-1 access with named prescribers and 4-pharmacy network
Pricing Compare
Get started →GobyMeds
Budget-conscious shoppers
Pricing Compare
Get started →